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INTRODUCTION
Diabetic nephropathy and vascular changes remain major
complications of diabetes, accounting for up to 40% of cases
with end-stage renal disease and 75% of cases with cardio-
vascular disease (1). Many studies suggest a key role for hyper-
glycemia in the pathogenesis of these complications (2, 3).
Indeed, elevated glucose is known to activate a variety of cells
to stimulate extracellular matrix (ECM) synthesis including
collagen mediated by stimulating transforming growth fac-
tor (TGF)-β(2, 4, 5).
Pathologic changes in the glomerular ECM lead to abnor-
mal protein excretion as well as to impairment of glomeru-
lar filtration in diabetic nephropathy. Alterations in the dia-
betic glomerular basement membrane (GBM) include in-
crease in its thickness and decrease in the density of anionic
sites (6). The former corresponds to increase in GBM con-
tent of collagen forming mesh-like barrier structure which
regulates the size-selective aspects of glomerular permselec-
tivity (1-3).
GBM are assembled through an interweaving of type IV
collagen (collagen IV) with laminins, nidogen, and sulfated
proteoglycans (7-9). Collagen IV belongs to a family of collage-
nous proteins that has at least 25 distinct members. The CO-
L4A1, COL4A2, COL4A3, COL4A4, COL4A5, and COL4A6
genes encode the six chains of collagen IV, α 1(IV) through
α 6(IV) (9-11). Type IV collagen chains have a highly regu-
lated distribution in the glomerulus; α 1 and α 2 chains are
localized to the mesangium, whereas α 3 through α 6 chains
are found mainly in the GBM (9-13). Type IV collagen of
GBM is produced by and attached to podocytes, therefore,
type IV collagen of GBM is closely related to podocytes. Dys-
regulation of GBM collagen chains produces proteinuria and
hematuria as seen in Alport’s syndrome and Goodpasture syn-
drome clinically (10, 11). However, the dysregulation of cel-
lular metabolism of individual chains of type IV collagen in
podocytes (glomerular epithelial cells; GEpC) has not been
well studied in diabetic nephropathy. Our aim in this study
was to investigate the regulation of αchains of type IV col-
lagen of podocytes that is responsible for the synthesis of GBM
in diabetic condition.
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Regulation of Type IV Collagen α αChains of Glomerular Epithelial
Cells in Diabetic Conditions 
An early feature of diabetic nephropathy is the alteration of the glomerular basement
membrane (GBM), which may result in microalbuminuria, subsequent macropro-
teinuria, and eventual chronic renal failure. Although type IV collagen is the main
component of thickened GBM in diabetic nephropathy, cellular metabolism of each
α chains of type IV collagen has not been well studied. To investigate the regulation
of α (IV) chains in diabetic conditions, we examined whether glucose and advanced
glycosylation endproduct (AGE) regulate the metabolism of each α (IV) chains in the
diabetic tissue and glomerular epithelial cells (GEpC). Glomerular collagen α 3(IV)
and α 5(IV) chains protein were higher and more intense in immunofluorescence
staining according to diabetic durations compared to controls. In vitro, mainly high
glucose and partly AGE usually increased total collagen protein of GEpC by [
3H]-
proline incorporation assay and each α (IV) chain proteins including α 1(IV), α 3(IV),
and α 5(IV) in time-dependent and subchain-specific manners. However, the changes
of each α (IV) chains mRNA expression was not well correlated to the those of each
chain proteins. The present findings suggest that the metabolism of individual α (IV)
chains of GBM is differentially regulated in diabetic conditions and those changes
might be induced not only by transcriptional level but also by post-translational modi-
fications.
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Diabetic animals
Diabetes was induced by a single intravenous injection of
streptozotocin (STZ; Sigma Chemical Co., St. Louis, MO,
U.S.A.) at 45 mg/kg body weight, freshly dissolved in 0.1 M
sterile sodium citrate, pH 4.5, in 6-week-old (180-220 g) male
Sprague-Dawley rats. The rats were considered diabetic if
blood glucose levels were above 200 mg/dL at 48 hr after STZ
injection. The rats remained hyperglycemic throughout experi-
ment were sacrificed at 48 hr, 4 weeks and 10 weeks after the
induction of diabetes. The right kidney was removed, weighed,
cut into portions, and sectioned at 5 μ m for the assessment
of immunofluorescence (IF). 
Cell culture 
Rat GEpCs, cloned from primary rat glomerular cultures,
were characterized and provided by Kreisberg (14). They were
characterized by sensitivity to puromycin aminonucleoside,
positive staining for Heymann antigen (gp330) and podoca-
lyxin, whereas negative staining for factor VIII (15). GEpCs
were maintained as previously described (15). Experiments
were performed with cells between passages 15 and 18.
Preparation of culture additives
Cells were serum-deprived to reduce background for 24 hr
before each experiment, then exposed to glucose and/or AGE.
Rat GEpCs were incubated in culture media containing either
5 mM glucose with 66 unit/mL insulin or 30 mM glucose
(high glucose, HG) without insulin in order to mimic the
metabolic environment of type I diabetes mellitus. Advanced
glycosylation endproducts (AGE) was produced by the tech-
nique previously described by Ha et al. (15). To imitate the
long-term diabetic condition, AGE was added (5 μ g/mL) and
controls were established using unmodified bovine serum albu-
min (BSA) (5 μ g/mL). To exclude the effect of additionally
produced glycated proteins in culture conditions, no longer
than 48 hr of incubation was used. Fetal bovine serum (FBS)
was reduced to 0.5% on the last media change to reduce back-
ground before protein and RNA extraction. For identifica-
tion purposes, coating with AGE or BSA was denoted as ‘A’
or ‘B’, and addition of glucose at 5 or 30 mM by ‘5’ or ‘30’,
respectively. Their meaning of each condition described before
(15). 
[
3H]-proline incorporation 
Collagen synthesis was assessed by measurement of cellu-
lar [3H]-proline uptake. For all experiments, [3H]-proline
(PerkinElmer, Boston, MA, U.S.A.) was added to each well
at a final concentration of 1 μ Ci/mL for the last 24 hr in trip-
licate. After incubation, the media was removed and the cells
were washed with ice-cold 10% trichloroacetic acid (TCA)
for 30 min at 4℃. After two rinses with cold 10% TCA, the
acid-precipitable material was solubilized overnight in 1N
NaOH at 37℃and neutralized with 1N HCl per well. Total
protein was determined from an aliquot of each well by Brad-
ford assay (Sigma Chemical Co., St. Louis, MO, U.S.A.). Incor-
porated radioactivity (dpm) from the resultant supernatant
was measured in a liquid scintillation counter and was ex-
pressed as percent of control.
Cellular protein extraction 
For measuring collagen, cell extracts were prepared from rat
GEpCs grown for each duration period under different condi-
tions as described before. At the end of incubation, the con-
fluently grown cell layers were washed twice with phosphate-
buffered saline and subsequently extracted in 4 M guanidi-
nium-HCl, 2% CHAPS, and protease inhibitors containing
100 mM 6-aminohexanoic acid, 10 mM benzamidine HCl,
and 1 mM phenylmethylsulfonyl fluoride (PMSF) at 4℃
overnight and stored at -20℃ till further analysis. Protein
concentrations were determined with a Bio-Rad kit (Bio-Rad
Laboratories, Hercules, CA, U.S.A.). 
Western blotting of collagen α αchains
Thirty μ g of boiled extracts was applied on 10% SDS-PAGE
gels and transferred to polyvinylidene fluoride membranes
(Bio-Rad Laboratories). Then, the membranes were air-dried
and blocked in 3% fat-free milk before incubation with mon-
oclonal goat anti-rat collagen α 1, α 3, and α 5 chains (Santa
Cruz Biotechnology, Santa Cruz, CA, U.S.A.). After incuba-
tion with horseradish peroxidase-conjugated secondary anti-
bodies, bands were detected by using the ECL chemilumines-
cence system (Amersham Biotech Ltd., Bucks, U.K.). Each
band density was measured using densitometry program (Lab-
Works 4.0, UVP Inc., Upland, CA, U.S.A.) and controlled
by β -actin amounts.
RT-PCR analysis of collagen α αchains
Total RNA was extracted from cultured rat GEpC as pre-
viously described (15). After estimating its concentration by
UV spectrophotometry, 5 μ g of total RNA was used for first-
strand cDNA synthesis. Aliquots of the cDNA were ampli-
fied using primers for collagen α 1(IV): sense 5′ -TCGGCTA-
TTCCTTCGTGATG-3′ and anti-sense 5′ -TCTCGCTTC-
TCTCTATGGTG-3′ ; α 3(IV): sense 5′ -ATCCTGGTCTTC-
CTGGACCT-3′ and anti-sense 5′ -CCATCTCACCAGGA-
CAACCT-3′ ; collagen α 5(IV): sense 5′ -ATGCTGACTAG-
CAACCATGA-3′ and anti-sense 5′ -GCCAGATCACATC-
TAAATGA-3′ . The expression of GAPDH as RNA control
was analyzed employing the following primers: sense 5′ -CT-
838 T.-S. Ha, E.-J. Hong, E.-M. Ahn, et al.CTACCCACGGCAAGTTCAA-3′ and anti-sense 5′ -GGA-
TGACCTTGCCCACAGC-3′ . PCR products were visual-
ized on 2% agarose gels, and band density was measured using
densitometry program as Western blotting. 
Statistics 
The data (cpm per mg cell protein) in each condition of
incubation from at least three experiments were expressed
as mean±SD if not remarked and compared by Student’s t
test; P<0.05 was considered to be statistically significant.
RESULTS
Increased intensity of α α (IV) chains in diabetic glomeruli
Double-staining of α 5(IV) with P-cadherin and α 3(IV)
showed colocalization in podocyte foot processes around cap-
illary loops in rat glomeruli (Fig. 1A). The observed tissues
were obtained at 48 hr, 4 weeks and 10 weeks after the induc-
tion of diabetes, of them, urinary albumin excretion increased
significantly only in the prolonged diabetic rat (24.5 mg/day
at 10 weeks vs. less than 4 mg/day at 48 hr and 4 weeks). IF
microscopy of kidney stained with anti-α 3(IV) and α 5(IV)
antibodies showed that the increased and more intense stain-
ings of glomerular capillary α 3(IV) and α 5(IV) chains were
observed according to diabetic durations compared to con-
trols (Fig. 1B). There were no glomerular stainings in pri-
mary antibodies-negative controls (figures not shown). We
also found that there were glomerular hypertrophy and scle-
rosis in the advanced diabetic kidneys.
High glucose increases [
3H]-proline incorporation 
Compared to incubation of GEpC with 5 mM glucose (B5),
30 mM glucose without insulin (B30), AGE with 5 mM glu-
cose (A5), and AGE with 30 mM glucose (A30) for 48 hr
resulted in 55.5%, 20.6, and 50.3% increase in [3H]-proline
incorporation, respectively (Fig. 2). Therefore, the increase in
[3H]-proline incorporation meaning collagen synthesis might
be induced mainly by high glucose. 
High glucose increases α αchains of type IV collagen by
western analysis 
The protein amounts of novel glomerular collagen αchains
proteins, α 3(IV) and α 5(IV) chains, were compared with that
α (IV) Chains of Podocyte in Diabetic Conditions 839
×1,000). (B) Immunofluorescence microscopy of rat kidney tissue stained with anti-α 3(IV) and α 5(IV) antibodies at each experimental
time (magnification ×400). The further diabetic nephropathy advanced, the more intense stainings of α 3(IV) and α 5(IV) chains along the
glomerular capillaries were observed compared with those of age-matched controls.
Fig. 1. Immunofluorescence staining of α 3(IV) and α 5(IV) in rat
tissues. (A) Double-staining of α 5(IV) with P-cadherin and α 3(IV)
showed colocalization in podocyte foot processes around cap-
illary loops in rat glomeruli at 48 hr of diabetes (magnification
A
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Fig. 2. [
3H]-Proline incorporation by high glucose and AGE. High
glucose increased [
3H]-proline incorporation of GEpC significant-
ly (*P<0.05).
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106.3of condition B5 at 2, 8, 24, and 48 hr incubation time. Both
α 3(IV) and α 5(IV) chains, were not changed initially, then,
increased at 48 hr by high glucose (Fig. 3A, B). AGE did not
showed any additive effect on the novel αchains proteins,
although α 5(IV) chain protein increased somewhat since 24
hr incubation. Then, we observed the changes of α 1(IV) and
α 5(IV) chains proteins at 48 hr incubation.
Densitometric analysis of α 1(IV) chain by Western blot-
ting revealed a 46% increase in high glucose condition (B30)
and 50% increase in high glucose and AGE condition (A30)
at 48 hr incubation compared to B5 (n=3, P<0.05, both, Fig.
3C). However, these changes were not found in the A5 and
osmotic control (Aosm). α 5(IV) chain also revealed a 66%
increase in high glucose condition (B30) and 2.2 fold increase
in high glucose and AGE condition (A30) compared to B5
(n=3, P<0.05, both, Fig. 3D). However, these changes were
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Fig. 3. Effects of glucose and AGE on the α (IV) chains protein in cultured GEpC assayed by Western blotting. (A) Sequential changes of
α 3(IV) proteins, (B) Sequential changes of α 5(IV) proteins ; Both α 3(IV) and α 5(IV) chains were not changed initially, then, increased at 48
hr by high glucose, (C) High glucose (B30 and A30) increased the amounts of α 1(IV) proteins significantly compared with group B5, (D)
High glucose (B30 and A30) increased the amounts of α 5(IV) proteins significantly compared with group B5. Data on the densitometric
analysis of α 1(IV) and α 5(IV)/β -actin ratio are expressed as mean±SD. Control (100%); the value of B5. *P<0.05 versus control. 
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Fig. 4. Regulation of α (IV) chains mRNA in cultured GEpC assayed by RT-PCR. Sequential changes of α 1(IV) mRNA (A), α 3(IV) mRNA (B),
α 5(IV) mRNA (C). (D) High glucose and AGE (A30) increased the amounts of α 1(IV) mRNA significantly at 48 hr incubation compared with
group B5. Change of α 3(IV) mRNA (E) and α 5(IV) mRNA (F) at 48 hr incubation. Data on the densitometric analysis of each α (IV)/GAPDH
ratio are expressed as mean±SD. Control (100%); the value of B5. *P<0.05.
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of α 1(IV) chain. The increased amount of α 1 and α 5 chains
protein in high glucose-added conditions (B30 and A30) was
much more than that of A5 and Aosm, implying that high
glucose might have more influence on the amount of α 1 and
α 5 chains protein of GEpC than AGE and osmolality. 
Gene expression of α αchains of type IV collagen by high
glucose and AGE
The expression levels of mRNA for α 1(IV), α 3(IV), and
α 5(IV) in each condition were compared with that of condi-
tion B5 at 2, 8, 24, and 48 hr incubation time. GAPDH
mRNA was not significantly different in all PCR products.
According to incubation time, mRNA expression of each α
chain showed the slightly increasing tendency in chain-dif-
ferent manners, however, their significances were rare (Fig.
4A-C). Then, we observed the changes of each chains expres-
sion at 48 hr incubation.
There were significantly increased α 1(IV) chain mRNA
only in A30 condition (25%, compared with B5 (P<0.05),
however, no significant changes in the other conditions (Fig.
4D). And, there are no significant changes of α 3(IV) and α 5(IV)
chains mRNA in any conditions (Fig. 4E, F). Fig. 4C showed
that the expression levels of mRNA for α 5(IV) in each con-
dition increased compared with those of condition B5 at early
stages, 2, 8, and 24, however, not at 48 hr incubation time
in Fig. 4F. 
DISCUSSION
Diabetic glomerulopathy is characterized by thickening of
the GBM and expansion of the mesangial matrix (6, 16). An
early feature of diabetic nephropathy is the alteration of the
glomerular basement membrane (GBM), which may result
in microalbuminuria, subsequent overt proteinuria, and even-
tual renal failure (1, 3). As for the GBM, its conspicuous thick-
ening in diabetes, perhaps due to accumulation of collagen
IV and alterations in its architecture and composition (6, 16,
17), would seem to constitute a more effective barrier to the
filtration of proteins but is in fact more porous to proteins
(18). The glomerular visceral epithelial cell, called podocyte
is also affected by the early pathologic changes in diabetic
glomerulopathy, including overproduction of cytokines such
as VEGF and TGFβ , widened foot processes width (hyper-
trophy), podocytopenia, and the dysregulation of GBM com-
ponents, all of which contribute to the initiation of protein-
uria and progression of renal disease (18-20). Because the onset
and progression of diabetic glomerulosclerosis are delayed in
patients who achieve an adequate level of glycemic control
(21), hyperglycemia is thought to be an important regulator
of glomerular lesion development.
GBM is composed of several macromolecules, including
type IV collagen, laminin, proteoglycan, and entactin (7-9).
Type IV collagen, which includes six genetically distinct iso-
forms named α 1(IV) through α 6(IV) (9-11), is the most abun-
dant constituent of the GBM (7-9, 12). These isoforms orga-
nize themselves into a unique network, which provides GBM
structural stability and unique functionality (7, 12). Differ-
ent isoforms of type IV collagen are specific for each glomeru-
lar compartment. The novel α 3(IV), α 4(IV), and α 5(IV) chains
are predominantly associated with the GBM, while classical
α 1(IV) and α 2(IV) chains are present in the mesangial matrix
(9-13, 16). 
At all developmental stages of kidney morphogenesis, α 1
and α 2(IV) chains were seen in basement membranes. Col-
lagen α 3-5(IV) chains, on the other hand, were not found in
fetal nephron at the primary vesicle, S-shaped body and cap-
illary loop stages but emerged during later development of
the nephron. This is in line with earlier studies on rat tissues
suggesting that in the rat, α 3-5(IV) chains are first expressed
and start replacing α 1 and α 2(IV) chains in glomerulus at the
capillary loop stage (22). In the human kidney, however, this
switch seems to appear at a distinctly later stage of develop-
ment, reflecting species-specific differences in kidney develop-
ment. Human kidney also shows expression of α 1 and α 2(IV)
chains in GBM, which is not seen in developing rat kidney
(22, 23).
Dysregulation of GBM collagen chains produces protein-
uria and hematuria genetically or acquired as seen in Alport’s
syndrome and Goodpasture syndrome, respectively (10, 11).
However, the dysregulation of cellular metabolism of indi-
vidual chains of type IV collagen has not been well studied
in diabetic nephropathy. 
In STZ-induced diabetic rats, the mRNA levels for the α 1
(IV) collagen chain increased significantly with age even before
morphological thickening of basement membrane occurred
(24). Treating the diabetic rats with insulin for 4 weeks ame-
liorated the abnormally regulated ECM gene expression in
the glomeruli (24). These data suggest that hyperglycemia
may play a role in the abnormal ECM gene expression in vivo.
The mRNA levels for the α 5(IV) collagen chain also increas-
ed significantly in STZ-induced diabetic rats at month 1 but
not at month 4, whereas collagen α 5(IV) protein was higher
at both 1 and 4 months (25). We also found that both novel
collagen chains, α 3(IV) and α 5(IV) chains, increased in the
GBM of experimental overt diabetic tissues as seen in Fig. 1.
In the db/db mice, there was a significant reduction of α 3(IV)
collagen protein in renal cortex but not of α 5(IV) collagen
subchain in compared with the db/m controls (26). In human
diabetic kidney tissue, there was intense staining for α 3(IV)
NC and α 4(IV) NC domain in the GBM but not in the me-
sangial matrix of type I and type II diabetic patient tissue
with overt diabetic nephropathy (27, 28). In contrast, stain-
ing with antibodies to α 1(IV) NC and α 2(IV) NC domain
reacted with mesangial matrix but appeared to diminish sig-
nificantly in the GBM in the patients with overt diabetic
α (IV) Chains of Podocyte in Diabetic Conditions 841nephropathy (27, 28). 
In vitro study, Kang et al. (25) reported that collagen α 5
(IV)/GAPDH mRNA ratio and protein of cultured mouse
podocytes were higher in high glucose for 10 days incubation
than in low (normal) glucose. These results are similar to our
results on the change of α 5 chain mRNA levels at early stages
although not significant later, as cultured cells might not be
identical. On the other hand, Bai et al. (29) demonstrated
using cultured mouse podocytes that high glucose decreased
the protein levels of α 5(IV) chain significantly during 3-4 days
incubation, whereas, increased MMP-9 activity and mRNA
levels, suggesting that the change of GBM collagen would
be caused by an imbalance in ECM synthesis and degrada-
tion. We also found that high glucose induced the increased
amount of α 1(IV), α 3(IV), and α 5(IV) chains protein at late
stage. On the other hand, high glucose induced the mRNA
expression of α 5(IV) and partly α 1(IV) at early stage but not
at late stage. The incoordination between α (IV) chains protein
and their mRNA expression at each stage suggest that the
increased amount of α 5(IV) chains protein in high glucose-
added conditions may be induced by transcriptional metabol-
ic imbalance at early stage but much more by post-transla-
tional modification including structural changes by glycosy-
lation mostly at late stage. On the other hand, the other α (IV)
chains might be regulated much more by post-translational
modification including structural changes by glycosylation
and/or metabolic imbalance in time-dependent and isoform-
specific manners. Similarly, AGE also induced the increased
amount of α 1(IV), α 3(IV), and α 5(IV) chains protein at late
stage and the mRNA expression of α 5(IV) at early stage and
α 1(IV) at late stage. These changes induced by AGE also sug-
gest that α (IV) chains might be regulated not only by tran-
scriptional level but also by post-translational modification
including structural changes by glycosylation and/or metabol-
ic imbalance in time-dependent and subchain-specific man-
ners. Additive effects by AGE were not evident. 
Although the mechanisms of increased each αchains of type
IV collagen would not be clearly elucidated because of their
different expressions, many researchers suggested the roles
of angiotensin II (30), TGF-β , PKC-p38 MAPK signaling
(25), insulin (24), decreased matrix degradation (28), etc. as
the initiator and modulator of type IV collagen dysregulation
in diabetic environments. According to the our present and
previous studies, diabetic conditions induced the dysregula-
tion of glomerular α (IV) chains by transcriptional and post-
translational modification with a discrepancy in the species-,
strains-, time-, cell-, and/or subchain-dependent manners.
The mechanisms of the changes of type IV collagen αchains
would be further elucidated for the regulation of type IV col-
lagen biosynthesis.
In conclusion, we suggest that the metabolism of individ-
ual α (IV) chains of GBM is differentially regulated in diabet-
ic conditions and the change of each αchains would be in-
duced by transcriptional level and post-translational modifi-
cation including structural changes by glycosylation and/or
metabolic imbalance in time-dependent and isoform-specif-
ic manners. 
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